Bextra and Fibula fracture - a phase IV clinical study of FDA data

Summary:

Fibula fracture is reported as a side effect among people who take Bextra (valdecoxib), especially for people who are female, 50-59 old, also take Depo-Medrol, and have Osteoporosis.

The phase IV clinical study analyzes which people have Fibula fracture when taking Bextra. It is created by eHealthMe based on reports of 20,982 people who have side effects when taking Bextra from the FDA, and is updated regularly.

What is Bextra?

Bextra has active ingredients of valdecoxib. It is often used in pain. eHealthMe is studying from 20,994 Bextra users. Check the latest studies of Bextra.

What is Fibula fracture?

Fibula fracture is found to be associated with 561 drugs and 581 conditions by eHealthMe. Check the latest studies of Fibula fracture.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

20,982 people reported to have side effects when taking Bextra.
Among them, 30 people (0.14%) have Fibula fracture.

$Could Bextra cause Fibula fracture?$

Among these 30 people:

What is the gender of people who have Fibula fracture when taking Bextra? *

female: 96.55 %
male: 3.45 %

What is the age of people who have Fibula fracture when taking Bextra? *

What are other drugs people take besides Bextra? *

What are other side effects people have besides Fibula fracture? *

Foot Fracture: 29 people, 96.67%
Injury: 29 people, 96.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 29 people, 96.67%
Stress And Anxiety: 28 people, 93.33%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 28 people, 93.33%
Oedema Peripheral (superficial swelling): 28 people, 93.33%
Fall: 28 people, 93.33%
Depression: 26 people, 86.67%
Osteonecrosis Of Jaw (death of bone of jaw): 24 people, 80.00%
Insomnia (sleeplessness): 23 people, 76.67%

What are the existing conditions these people have? *

Bone Density Abnormal: 16 people, 53.33%
Osteoporosis (bones weak and more likely to break): 16 people, 53.33%
Breast Cancer: 10 people, 33.33%
Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 10 people, 33.33%
Metastases To Bone (cancer spreads to bone): 10 people, 33.33%
Breast Cancer Metastatic: 2 people, 6.67%
Thrombocytopenia (decrease of platelets in blood): 1 person, 3.33%
Indigestion: 1 person, 3.33%
Blood Pressure Abnormal: 1 person, 3.33%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bextra and have Fibula fracture?

- Check whether Fibula fracture is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bextra:

Bextra (20,994 reports)

Fibula fracture treatments and more:

Fibula fracture (4,153 reports)

Browse all side effects of Bextra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fibula fracture:

Fibula fracture (561 drugs)

Browse all the conditions that are associated with Fibula fracture:

Fibula fracture (581 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valdecoxib (the active ingredients of Bextra) and Bextra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.